Symbol Name ID |
Gfap
glial fibrillary acidic protein MGI:95697 |
* | Aspects of the system are reported to show a normal phenotype. |
Darker colors indicate more annotations |
Human Phenotypes | Increased CSF protein concentration |
Spasticity |
Diffuse demyelination of the cerebral white matter |
Hydrocephalus |
Abnormal dentate nucleus morphology |
Ataxia |
Dysmetria |
Palatal tremor |
Babinski sign |
Dysarthria |
Apathy |
Drowsiness |
Bulbar signs |
Developmental regression |
Seizure |
Disease(s) Associated with GFAP | |||||||||||||||
Alexander disease |
Mouse Phenotypes | nervous system phenotype |
increased susceptibility to pharmacologically induced seizures |
abnormal blood-brain barrier function |
abnormal brain iron level |
non-obstructive hydrocephaly |
abnormal brain white matter morphology |
decreased corpus callosum size |
abnormal CNS glial cell morphology |
abnormal astrocyte morphology |
abnormal oligodendrocyte morphology |
gliosis |
abnormal oligodendrocyte physiology |
abnormal myelination |
abnormal excitatory postsynaptic potential |
enhanced long-term potentiation |
reduced long-term depression |
|
Availability | Mouse Genotype | ||||||||||||||||
Gfaptm1Ito/Gfaptm1Ito | * | ||||||||||||||||
Gfaptm1Ldtk/Gfaptm1Ldtk | |||||||||||||||||
Gfaptm1Mes/Gfaptm1Mes | |||||||||||||||||
Gfaptm1Pkny/Gfaptm1Pkny | * | ||||||||||||||||
Gfaptm2Ito/Gfaptm2Ito | * | ||||||||||||||||
Gfaptm2Mes/Gfaptm2Mes | |||||||||||||||||
Gfaptm3Ito/Gfaptm3Ito | |||||||||||||||||
Gfaptm3Mes/Gfaptm3Mes | |||||||||||||||||
Gfaptm4Ito/Gfaptm4Ito | |||||||||||||||||
Gfaptm2Mes/Gfap+ | |||||||||||||||||
Gfaptm3Mes/Gfap+ |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/23/2024 MGI 6.23 |
|
|